You have 9 free searches left this month | for more free features.

anti-tuberculosis drug

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tuberculosis, Drug Induced Liver Injury, Hepatitis Trial in Bangkok (N acetyl cysteine)

Recruiting
  • Tuberculosis
  • +2 more
  • N acetyl cysteine
  • Bangkok, Thailand
    Faculty of Medicine, Siriraj Hospital
Feb 12, 2023

Tuberculosis Infection Trial in Zurich (Nivaquine ® (Chloroquine))

Recruiting
  • Tuberculosis Infection
  • Nivaquine ® (Chloroquine)
  • Zurich, Switzerland
    Clinical Trial Center
Jun 28, 2022

Tuberculous Uveitis Trial in Jakarta Pusat (Anti Tuberculosis Drug, Prednisone tablet)

Enrolling by invitation
  • Tuberculous Uveitis
  • Anti Tuberculosis Drug
  • Prednisone tablet
  • Jakarta Pusat, DKI Jakarta, Indonesia
    Cipto Mangunkusumo National Central General Hospital
Sep 12, 2021

Multi-drug Resistant Tuberculosis Trial in China (18-month regimen containing 6 anti-TB drugs)

Completed
  • Multi-drug Resistant Tuberculosis
  • 18-month regimen containing 6 anti-TB drugs
  • Beijing, China
  • +19 more
Oct 10, 2022

TB-CAPT MTB/XDR Study

Recruiting
  • Tuberculosis
  • +2 more
  • Xpert MTB/XDR
  • Cape Town, South Africa
  • +1 more
May 17, 2021

Tuberculosis Drug Levels in Diabetics

Not yet recruiting
  • Tuberculosis
  • Diabetes Mellitus
  • Measurement of tuberculosis medications level
  • (no location specified)
Apr 14, 2021

Tuberculosis, Pulmonary, Tuberculosis Trial in Ile Ife, Birmingham (Atorvastatin with standard anti tuberculosis drugs, Anti

Unknown status
  • Tuberculosis, Pulmonary
  • Tuberculosis
  • Atorvastatin with standard anti tuberculosis drugs
  • Anti tuberculosis drugs only
  • Ile Ife, Osun, Nigeria
  • +1 more
Feb 5, 2021

Tuberculous Lymphadenitis Trial in Taipei (Prednisolone, standard anti-tuberculosis agents)

Recruiting
  • Tuberculous Lymphadenitis
  • Taipei, Taiwan
    National Taiwan University Hospital
May 17, 2023

d to Treat Drug Sensitive Tuberculosis in Breastfeeding

Recruiting
  • Tuberculosis Active
  • +2 more
  • First line tuberculosis treatment
  • Kampala, Uganda
    Infectious Diseases Institute
Apr 22, 2023

Tuberculosis, Pulmonary Trial in Houston (Azacitidine Injection)

Not yet recruiting
  • Tuberculosis, Pulmonary
  • Azacitidine Injection
  • Houston, Texas
    Harris Health System - Ben Taub Hospital
Sep 1, 2022

Tuberculosis, MDR Trial in Kazakhstan, Kyrgyzstan (FS-1, Placebo)

Completed
  • Tuberculosis, MDR
  • Semey, East-Kazakhstan Region, Kazakhstan
  • +5 more
May 17, 2022

Tuberculosis, Drug-resistant Tuberculosis, Isoniazid Resistant Tuberculosis (Disorder) Trial in Chennai (High dose isoniazid)

Completed
  • Tuberculosis
  • +2 more
  • High dose isoniazid
  • Chennai, Tamil Nadu, India
    National Institute for Research on Tuberculosis
Oct 13, 2020

CD4/CD8+ Interferon Gamma Release Assay for Monitoring

Active, not recruiting
  • Tuberculosis
  • Interferon gamma release assay (IGRA)
  • Milano, Italy
    IRCCS San Raffaele Scientific Institute
Feb 13, 2023

Pharmacometrics to Advance Novel Regimens for Drug-resistant

Recruiting
  • Multi-drug Resistant Tuberculosis
    • Almaty, Kazakhstan
    • +6 more
    Nov 1, 2022

    Tuberculosis, Pulmonary, HIV Trial in Port-au-Prince, Cape Town (Bedaquiline, Clofazimine, Pyrazinamide)

    Not yet recruiting
    • Tuberculosis, Pulmonary
    • HIV
    • Port-au-Prince, Haiti
    • +1 more
    Nov 11, 2022

    Adequacy of New Pediatric Isoniazid/Rifampin/Pyrazinamide Tablet

    Recruiting
    • Tuberculosis
    • +2 more
    • Observational PK study
    • Kumasi, Ghana
      Kwame Nkrumah University of Science and Technology
    Dec 21, 2022

    MDR-TB Trial in Worldwide (Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline), Moxifloxacin, Clofazimine)

    Active, not recruiting
    • MDR-TB
    • Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline)
    • +9 more
    • Addis Ababa, Ethiopia
    • +12 more
    Oct 12, 2022

    Interferon Gamma Injections in Drug-resistant Pulmonary

    Recruiting
    • Pulmonary Tuberculosis
    • Moscow, Russian Federation
      FSBI "NMIC FPI" of the Ministry of Health of Russia
    May 31, 2022

    Tuberculosis, Pre-XDR-TB, Extensively Drug-Resistant Tuberculosis Trial in Port Elizabeth (Bedaquiline Oral Tablet, Linezolid

    Active, not recruiting
    • Tuberculosis
    • +4 more
    • Bedaquiline Oral Tablet
    • +7 more
    • Port Elizabeth, Eastern Cape, South Africa
    • +1 more
    Oct 20, 2022

    Pulmonary Tuberculosis Trial (Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS), Pretomanid, Bedaquiline, OPC-167832, and

    Not yet recruiting
    • Pulmonary Tuberculosis
    • Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS)
    • +3 more
    • (no location specified)
    Jul 25, 2023

    Tuberculosis Trial in H?i Phòng (Community based TB intervention)

    Not yet recruiting
    • Tuberculosis
    • Community based TB intervention
    • Hải Phòng, Vietnam
    • +1 more
    Dec 15, 2022

    Continuous Glucose Monitoring in Diabetic Patients

    Recruiting
    • Tuberculosis
    • Diabetes Mellitus
    • TB Drug Levels
    • London, United Kingdom
      London North West University NHS University Trust
    Apr 7, 2022

    Kidney Transplant Infection, Tuberculosis, Isoniazid Toxicity Trial (Isoniazid, without any additional anti-tuberculosis

    Not yet recruiting
    • Kidney Transplant Infection
    • +2 more
    • Isoniazid
    • without any additional anti-tuberculosis treatment
    • (no location specified)
    Mar 21, 2022

    Drug-resistant Tuberculosis, HIV Coinfection, Cost-Benefit Analysis Trial in Cape Town (Targeted next-generation sequencing)

    Not yet recruiting
    • Drug-resistant Tuberculosis
    • +2 more
    • Targeted next-generation sequencing
    • Cape Town, South Africa
      South African National Health Laboratory Service
    Sep 23, 2022

    Tuberculosis, Human Immunodeficiency Virus Trial (Optimised rifamycin)

    Not yet recruiting
    • Tuberculosis
    • Human Immunodeficiency Virus
    • Optimised rifamycin
    • (no location specified)
    Oct 8, 2022